Watson Pharmaceuticals, Inc. today announced a new program encouraging health professionals to help maintain the bone health of prostate cancer patients who are on long-term androgen deprivation therapy (ADT).
Read more from the original source:
New program to help maintain bone health in men with prostate cancer on ADT announced (News-Medical-Net)
0 Responses to “New program to help maintain bone health in men with prostate cancer on ADT announced (News-Medical-Net)”